Pacific Biosciences of California Inc. buy Zacks Research
Start price
21.02.26
/
50%
€1.34
Target price
21.02.27
-
Performance (%)
-8.42%
Price
14.04.26
€1.33
Summary
This prediction is currently active. With a performance of -8.42%, the BUY prediction by Zacks_Research is trending in the wrong direction. This prediction currently runs until 21.02.27. The prediction end date can be changed by Zacks_Research at any time. Zacks_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | 6.541% | 6.541% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by Zacks_Research for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PACB provided by MarketBeat